| Financial Year |
March 31 2023 |
| Monetary Funds |
551,965,640.78 |
| Held-for-trading Financial Assets |
244,281,014.75 |
| Notes Receivable |
13,134,133.82 |
| Accounts Receivable |
957,121,543.49 |
| Advances to Suppliers |
1,687,512.51 |
| Other Receivables |
45,039,519.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,195,952.50 |
| Inventories |
230,473,290.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
147,893,883.66 |
| Other Current Assets |
36,581,360.18 |
| Total Current Assets |
3,796,190,628.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,391,905.01 |
| Long-term Equity Investment |
85,338,873.43 |
| Investment Properties |
41,411,190.71 |
| Fixed Assetes |
131,574,411.11 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
527,035,523.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,801,145.04 |
| Deferred Income Tax Assets |
241,172,421.46 |
| Other Non-Current Assets |
445,023,594.56 |
| Sub-Total of Non-Current Assets |
1,552,095,746.04 |
| Total Assets |
5,348,286,374.71 |
| Short-Term Loans |
12,673,800.32 |
| Trading Financial liabilities |
515,545.29 |
| Notes Payable |
27,097,941.24 |
| Accounts Payable |
1,625,531,673.45 |
| Accounts Received In Advance |
301,978.84 |
| Employee Compensation Payable |
13,309,113.11 |
| Taxes Payable |
1,285,751.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,516,360.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,832,557.41 |
| Other Current Liabilities |
153,117,466.37 |
| Sub-Total of Current Liabilities |
2,044,741,767.61 |
| Long-term Loans |
240,252,878.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,007,839.99 |
| Deferred Income Tax Liabilities |
1,387,601.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
250,463,819.05 |
| Total Liabilities |
2,295,205,586.66 |
| Paid-In Capital(Or Share Stock) |
1,795,890,452.00 |
| Capital Surplus |
1,978,393,994.17 |
| Surplus Reserve |
135,194,186.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-925,205,732.03 |
| Minority Stockholder's Interest |
63,122,919.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,989,957,868.30 |
| Owner's Equity（Stockholder's Equity） |
3,053,080,788.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,348,286,374.71 |
